Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 5;8(3):159.
doi: 10.3390/tropicalmed8030159.

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review

Affiliations
Review

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review

Yam B Limbu et al. Trop Med Infect Dis. .

Abstract

As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines will play an important role in personal and public health. However, convincing people to take boosters continues to be a key obstacle. This study systematically analyzed research that examined the predictors of COVID-19 booster vaccine hesitancy. A search of PubMed, Medline, CINAHL, Web of Science, and Scopus uncovered 42 eligible studies. Globally, the average COVID-19 booster vaccination hesitancy rate was 30.72%. Thirteen key factors influencing booster hesitancy emerged from the literature: demographics (gender, age, education, income, occupation, employment status, ethnicity, and marital status), geographical influences (country, region, and residency), adverse events, perceived benefit/efficacy, perceived susceptibility, perceived severity, prior history of COVID-19 infection, vaccination status, vaccination recommendations, health status, knowledge and information, skepticism/distrust/conspiracy theories, and vaccine type. Vaccine communication campaigns and interventions for COVID boosters should focus on factors influencing booster confidence, complacency, and convenience.

Keywords: COVID-19; booster; systematic review; vaccine hesitancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram showing search strategy.
Figure 2
Figure 2
COVID-19 booster vaccine hesitancy (CBVH) rate by study population and geographical region compared to the average CBVH rate of 30.7% across all included studies.

References

    1. World Health Organization WHO Coronavirus (COVID-19) Dashboard. 2023. [(accessed on 16 January 2023)]. Available online: https://worldhealthorg.shinyapps.io/covid/
    1. Batra K., Sharma M., Dai C.-L., Khubchandani J. COVID-19 Booster Vaccination Hesitancy in the United States: A Multi-Theory-Model (MTM)-Based National Assessment. Vaccines. 2022;10:758. doi: 10.3390/vaccines10050758. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention COVID-19 Vaccinations in the United States. [(accessed on 16 January 2023)];2023 Available online: https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-people-onedo....
    1. Kowalski E., Stengel A., Schneider A., Goebel-Stengel M., Zipfel S., Graf J. How to Motivate SARS-CoV-2 Convalescents to Receive a Booster Vaccination? Influence on Vaccination Willingness. Vaccines. 2022;10:455. doi: 10.3390/vaccines10030455. - DOI - PMC - PubMed
    1. Noh Y., Kim J.H., Yoon D., Choe Y.J., Choe S.A., Jung J., Lee S.W., Shin J.Y. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: A nationwide cross-sectional survey. Epidemiol. Health. 2022;44:e2022061. doi: 10.4178/epih.e2022061. - DOI - PMC - PubMed